Pfizer Inc. (NEO:PFE)

Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of CAD 195.44 billion. The enterprise value is 261.92 billion.

Market Cap	195.44B
Enterprise Value	261.92B

Important Dates

The last earnings date was Tuesday, November 4, 2025.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.18%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	65.99%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 14.26 and the forward PE ratio is 7.89.

PE Ratio	14.26
Forward PE	7.89
PS Ratio	2.23
PB Ratio	1.51
P/TBV Ratio	n/a
P/FCF Ratio	13.51
P/OCF Ratio	10.72
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.26, with an EV/FCF ratio of 18.10.

EV / Earnings	19.11
EV / Sales	2.96
EV / EBITDA	7.26
EV / EBIT	10.47
EV / FCF	18.10

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.67.

Current Ratio	1.28
Quick Ratio	0.90
Debt / Equity	0.67
Debt / EBITDA	2.42
Debt / FCF	5.97
Interest Coverage	6.59

Financial Efficiency

Return on equity (ROE) is 10.60% and return on invested capital (ROIC) is 7.04%.

Return on Equity (ROE)	10.60%
Return on Assets (ROA)	5.19%
Return on Invested Capital (ROIC)	7.04%
Return on Capital Employed (ROCE)	10.33%
Revenue Per Employee	1.08M
Profits Per Employee	169,193
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.36

Taxes

Income Tax	-955.10M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.85% in the last 52 weeks. The beta is 0.43, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	-12.85%
50-Day Moving Average	11.28
200-Day Moving Average	11.31
Relative Strength Index (RSI)	45.48
Average Volume (20 Days)	170,622

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.03

Income Statement

In the last 12 months, Pfizer had revenue of CAD 87.54 billion and earned 13.70 billion in profits. Earnings per share was 2.41.

Revenue	87.54B
Gross Profit	65.49B
Operating Income	24.79B
Pretax Income	12.76B
Net Income	13.70B
EBITDA	34.10B
EBIT	24.79B
Earnings Per Share (EPS)	2.41

Balance Sheet

The company has 20.89 billion in cash and 86.36 billion in debt, giving a net cash position of -65.47 billion.

Cash & Cash Equivalents	20.89B
Total Debt	86.36B
Net Cash	-65.47B
Net Cash Per Share	n/a
Equity (Book Value)	129.80B
Book Value Per Share	22.76
Working Capital	14.40B

Cash Flow

In the last 12 months, operating cash flow was 18.23 billion and capital expenditures -3.77 billion, giving a free cash flow of 14.47 billion.

Operating Cash Flow	18.23B
Capital Expenditures	-3.77B
Free Cash Flow	14.47B
FCF Per Share	n/a

Margins

Gross margin is 74.81%, with operating and profit margins of 28.31% and 15.66%.

Gross Margin	74.81%
Operating Margin	28.31%
Pretax Margin	14.58%
Profit Margin	15.66%
EBITDA Margin	38.96%
EBIT Margin	28.31%
FCF Margin	16.53%

Dividends & Yields

Pfizer does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	98.75%
Buyback Yield	-0.18%
Shareholder Yield	-0.18%
Earnings Yield	7.01%
FCF Yield	7.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	7